Daniel M. Junius, Chief Executive Officer at IMMUNOGEN INC (IMGN), sold 5,416 shares at $13.11 ($71K) on 2015-12-01, disclosed to the SEC on 2015-12-01.
Scheduled sale ($71k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IDXX | SELL | 2023-02-17 | $2.2M | — | Filing → |
| IDXX | SELL | 2022-12-07 | $2.6M | — | Filing → |
| GLYC | BUY | 2022-11-18 | $37K | — | Filing → |